Search Results

There are 2914 results for: content related to: Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis

  1. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  2. You have full text access to this OnlineOpen article
    A systematic review of treatment guidelines for metastatic colorectal cancer

    Colorectal Disease

    Volume 14, Issue 2, February 2012, Pages: e31–e47, M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber and D. P. Sykes

    Version of Record online : 10 JAN 2012, DOI: 10.1111/j.1463-1318.2011.02765.x

  3. You have free access to this content
    Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 1941–1950, Janghee Woo, Neil Palmisiano, William Tester and John C. Leighton Jr.

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.27994

  4. The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 891–897, Harold J. Wanebo and David Berz

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21691

  5. Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

    Cancer

    Volume 122, Issue 4, February 15, 2016, Pages: 574–581, Francesco Leone, Donatella Marino, Stefano Cereda, Roberto Filippi, Carmen Belli, Rosella Spadi, Guglielmo Nasti, Massimo Montano, Alessio Amatu, Giuseppe Aprile, Celeste Cagnazzo, Gianpiero Fasola, Salvatore Siena, Libero Ciuffreda, Michele Reni and Massimo Aglietta

    Version of Record online : 5 NOV 2015, DOI: 10.1002/cncr.29778

  6. You have free access to this content
    Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 3, August 2008, Pages: 269–281, M. PEETERS, J. BALFOUR and D. ARNOLD

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1365-2036.2008.03717.x

  7. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

    International Journal of Dermatology

    Volume 50, Issue 2, February 2011, Pages: 129–146, Yevgeniy Balagula, Claus Garbe, Patricia L. Myskowski, Axel Hauschild, Bernardo L. Rapoport, Christine B. Boers-Doets and Mario E. Lacouture

    Version of Record online : 19 JAN 2011, DOI: 10.1111/j.1365-4632.2010.04791.x

  8. Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1142–1156, Dr Peiming Ma, Dr Bing-Bing Yang, Dr Yow-Ming Wang, Dr Mark Peterson, Mr Adimoolam Narayanan, Ms Liviawati Sutjandra, Ms Rachelle Rodriguez and Dr Andrew Chow

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009344989

  9. You have free access to this content
    Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent

    British Journal of Pharmacology

    Volume 157, Issue 8, August 2009, Pages: 1541–1548, GL Ray, KE Baidoo, KJ Wong, M Williams, K Garmestani, MW Brechbiel and DE Milenic

    Version of Record online : 29 JUL 2009, DOI: 10.1111/j.1476-5381.2009.00327.x

  10. You have free access to this content
    Targeted therapies in squamous cell carcinoma of the head and neck

    Cancer

    Volume 115, Issue 5, 1 March 2009, Pages: 922–935, Kathryn A. Gold, Ho-Young Lee and Edward S. Kim

    Version of Record online : 20 JAN 2009, DOI: 10.1002/cncr.24123

  11. Preparation of clinical-grade 89Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 57, Issue 1, January 2014, Pages: 25–35, Ling Wei, Jianfeng Shi, George Afari and Sibaprasad Bhattacharyya

    Version of Record online : 13 NOV 2013, DOI: 10.1002/jlcr.3134

  12. Endothelial growth factor receptor inhibitors in recurrent metastatic cancer of the head and neck

    Head & Neck

    Volume 38, Issue S1, April 2016, Pages: E2221–E2228, Krzysztof Misiukiewicz, Rajan P. Dang, Michael Parides, Nadia Camille, Helen Uczkowski, Nicholas J. Sarlis and Marshall Posner

    Version of Record online : 5 NOV 2015, DOI: 10.1002/hed.24083

  13. You have free access to this content
    Individualized therapy for metastatic colorectal cancer

    Journal of Internal Medicine

    Volume 274, Issue 1, July 2013, Pages: 1–24, A. Silvestri, E. Pin, A. Huijbers, R. Pellicani, E. M. Parasido, M. Pierobon, E. Petricoin, L. Liotta and C. Belluco

    Version of Record online : 12 APR 2013, DOI: 10.1111/joim.12070

  14. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 35, Issue 3, March 2013, Pages: 443–453, Dong M. Shin and Fadlo R. Khuri

    Version of Record online : 2 NOV 2011, DOI: 10.1002/hed.21910

  15. You have free access to this content
    Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy

    Cancer

    Volume 115, Issue 7, 1 April 2009, Pages: 1544–1554, Marc Peeters, Salvatore Siena, Eric Van Cutsem, Alberto Sobrero, Alain Hendlisz, Stefano Cascinu, Haralabos Kalofonos, Giovanna Devercelli, Michael Wolf and Rafael G. Amado

    Version of Record online : 2 FEB 2009, DOI: 10.1002/cncr.24088

  16. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy

    Intervention Review

    The Cochrane Library

    Kelvin KW Chan, Anne-Marie Glenny, Jo C Weldon, Susan Furness, Helen V Worthington and Helen Wakeford

    Published Online : 1 DEC 2015, DOI: 10.1002/14651858.CD010341.pub2

  17. Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer

    Clinical Pharmacology in Drug Development

    Volume 2, Issue 3, July 2013, Pages: 205–212, Bing-Bing Yang, Chi-Yuan Wu, Eric Chen, Jeffrey R. Infante, Alin Chen, Bing Gao, Brian Smith, Jason Litten and Hagen Kennecke

    Version of Record online : 15 MAY 2013, DOI: 10.1002/cpdd.35

  18. You have free access to this content
    Update on monoclonal antibodies for the treatment of cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue s1, April 2011, Pages: 20–25, Ian D DAVIS

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1743-7563.2011.01384.x

  19. Molecular-targeted first-line therapy for advanced gastric cancer

    Intervention Review

    The Cochrane Library

    Huan Song, Jianwei Zhu and DongHao Lu

    Published Online : 19 JUL 2016, DOI: 10.1002/14651858.CD011461.pub2

  20. PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 38, Issue S1, April 2016, Pages: E1756–E1761, Danny Rischin, David R. Spigel, Douglas Adkins, Richard Wein, Susanne Arnold, Nimit Singhal, Oliver Lee and Swami Murugappan

    Version of Record online : 17 DEC 2015, DOI: 10.1002/hed.24311